经验证的黄斑变性进展预测模型及视力丧失预测因素可识别高风险个体
研究通过逐步生存分析确定进展为总体晚期年龄相关性黄斑变性(AMD)、地图样萎缩(GA)、新生血管病(NV)及视力丧失的预测因素与风险评分,并在大型独立队列中验证和校准AMD模型。13个基因位点复合模型12年年龄调整AUC为0.900(验证队列0.896),视力丧失的决定因素包括年龄、教育、体重指数、吸烟及多个常见和罕见遗传变异。
要点
- CFH、C3、ARMS2、COL8A1和HSPH1/B3GALTL基因的8个常见和罕见变异显著增加进展为晚期AMD风险。
- 13个基因位点复合模型12年年龄调整AUC为0.900,验证队列为0.896。
- 视力丧失的决定因素包括年龄、教育、体重指数、吸烟及多个常见和罕见遗传变异。
核心结论
- 基线黄斑分级相同的眼基于验证风险评分,后续进展和视力丧失的估计概率范围很宽。
- 利用预测模型在早期识别高风险个体,有望在精准医学时代改进预防和治疗策略。
研究设计与样本
- 采用逐步生存分析评估进展为晚期AMD,并推导包含遗传、人口学、行为和眼部因素的3个AMD终点风险评分。
- 风险评分在大型独立队列中进行验证和校准。
- 将15个或以上字母的视力丧失作为新终点进行遗传分析。
主要发现
- CFH、C3、ARMS2、COL8A1和HSPH1/B3GALTL基因的8个常见和罕见变异 confer 显著更高的进展为晚期AMD风险。
- 3个位点(C2、CFB、RAD51B)与较低的进展速率相关。
- CTRB1和PELI3提示保护效应。
- 考虑遗传因素时,进展者通常具有较高风险类别,非进展者具有较低风险类别。
- GA和NV的模型之间存在异质性。
关键数值与推荐
- 13个基因位点复合模型12年年龄调整AUC为0.900(验证队列0.896)。
- 视力丧失(15个或以上字母)的决定因素包括年龄、教育、体重指数、吸烟及多个常见和罕见遗传变异。
临床怎么用
- 在临床中可基于验证风险评分对基线黄斑分级相同的眼进行进展和视力丧失风险分层。
- 利用预测模型在早期识别高风险个体,以支持精准医学时代的预防和治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To determine predictive factors and risk scores for conversion to overall advanced age-related macular degeneration (AMD), geographic atrophy (GA), neovascular disease (NV), and loss of vision, and to validate the model for AMD in an external cohort. METHODS: Progression to advanced AMD was evaluated using stepwise survival analysis. Risk scores including genetic, demographic, behavioral, and ocular factors were derived for 3 AMD endpoints and were validated and calibrated in a large independent cohort. Vision loss of 15 or more letters was evaluated as a new endpoint in genetic analyses. RESULTS: Eight common and rare variants in genes CFH, C3, ARMS2, COL8A1, and HSPH1/B3GALTL conferred a significantly higher risk of transition to advanced AMD. Three loci (C2, CFB, RAD51B) were associated with lower rate of progression. A protective effect was suggested for CTRB1 and PELI3. The age-adjusted area under the curve (AUC) for the composite model including 13 loci model was 0.900 over 12 years (0.896 in the validation cohort). Generally, progressors had a higher risk category and nonprogressors had a lower risk category when genetic factors were considered. Furthermore, there was heterogeneity between models for GA and NV. The model was calibrated in the validation cohort. Determinants of visual loss included age, education, body mass index, smoking, and several common and rare genetic variants. CONCLUSION: Eyes with the same baseline macular grade had a wide range of estimated probability of subsequent progression and visual loss based on the validated risk score. Identifying high-risk individuals at an earlier stage using predictive modeling could lead to improved preventive and therapeutic strategies in the era of precision medicine.
引用
- Seddon JM, Rosner B. Validated Prediction Models for Macular Degeneration Progression and Predictors of Visual Acuity Loss Identify High-Risk Individuals. Am J Ophthalmol. 2018. PMID: 30389371. doi:10.1016/j.ajo.2018.10.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。